Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences
" "
SafetyAlerts
June 16, 1999

Gallipot, Inc. Recalls Trifluoperazine and Fluphenazine Hydrochloride Tablets

St. Paul, MN (SafetyAlerts) - The Food and Drug Administration (FDA) today reported that Gallipot, Inc. is recalling Liothyronine Sodium, USP, bulk powder in 1 and 5 gram containers.  This prescription used for the treatment of hypothyroidism has been recalled because the product is mislabeled and actually contains Levothyroxine Sodium.

CODE
9802163, 971257, 9808168, and 9802133.

MANUFACTURER
Gallipot, Inc., St. Paul, Minnesota.

RECALLED BY
Manufacturer, by telephone on or about January 28, 1999. Firm-initiated recall complete.

DISTRIBUTION
Nationwide.

QUANTITY
2 5-g containers and 10 1-gallon containers were distributed.

Recall #D-243-9.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.